When is Diabetes Diagnosed in Another Individual?
Diabetes is diagnosed when any of the following criteria are met: fasting plasma glucose ≥126 mg/dL, hemoglobin A1C ≥6.5%, random plasma glucose ≥200 mg/dL with classic symptoms, or 2-hour plasma glucose ≥200 mg/dL during a 75-g oral glucose tolerance test. 1, 2
Diagnostic Criteria
The diagnosis requires confirmation through repeat testing on a separate day, unless the individual presents with classic hyperglycemic symptoms (polyuria, polydipsia, unintentional weight loss) and a random plasma glucose ≥200 mg/dL—in which case a single test suffices 1.
Specific Thresholds:
- Fasting Plasma Glucose (FPG): ≥126 mg/dL (7.0 mmol/L)
- Hemoglobin A1C: ≥6.5%
- Random Plasma Glucose: ≥200 mg/dL (11.1 mmol/L) with symptoms
- 2-hour OGTT: ≥200 mg/dL (11.1 mmol/L) after 75-g glucose load
Who Should Be Screened?
Screen adults aged 40-70 years who are overweight or obese (BMI ≥25 kg/m²), repeating every 3 years if normal 2. However, Asian Americans require screening at lower BMI thresholds—approximately 15 pounds lower than other populations 1.
High-Risk Individuals Requiring Earlier/More Frequent Screening:
- Age ≥45 years (annual screening recommended)
- First-degree relative with diabetes
- History of gestational diabetes
- Physical inactivity
- High blood pressure
- Hispanic/Latino, African American, Native American, Asian American, Native Hawaiian, or Pacific Islander ethnicity
- History of cardiovascular disease
- Polycystic ovary syndrome
- Prediabetes on prior testing
Use the ADA Diabetes Risk Test: Individuals scoring ≥5 points are at increased risk and warrant formal testing 1.
Critical Diagnostic Pitfalls
Type 2 diabetes frequently remains undiagnosed for years because hyperglycemia develops gradually without obvious symptoms, yet these individuals already face increased macrovascular and microvascular complications 1. The presymptomatic phase is long, making screening essential rather than waiting for symptoms.
Do not rely solely on fasting glucose in populations where postprandial hyperglycemia predominates—many diabetic individuals would be missed using FPG alone, particularly in Asian and European populations 3. When FPG is mildly elevated (100-125 mg/dL), proceed with oral glucose tolerance testing 3.
Confirming Diabetes Type in Adults
When type 1 diabetes is suspected in adults (particularly those <35 years presenting without obesity), **test islet autoantibodies (GAD, IA-2, ZnT8)** 1. If autoantibody-negative and age >35 years, consider features of type 2 diabetes: BMI ≥25 kg/m², absence of weight loss, no ketoacidosis, family history, and metabolic syndrome features 1.
Measure C-peptide in insulin-treated patients to distinguish type 1 from type 2 diabetes: levels <200 pmol/L suggest type 1 diabetes, while >600 pmol/L indicates type 2 diabetes 1.
Gestational Diabetes Screening
Screen all pregnant individuals at 24-28 weeks gestation who haven't been previously diagnosed with diabetes 4.
One-Step Strategy (IADPSG Criteria):
Perform 75-g OGTT after overnight fast. Diagnose GDM if any one value meets or exceeds:
- Fasting: ≥92 mg/dL (5.1 mmol/L)
- 1-hour: ≥180 mg/dL (10.0 mmol/L)
- 2-hour: ≥153 mg/dL (8.5 mmol/L)
Two-Step Strategy:
Step 1: 50-g glucose load test (non-fasting); if 1-hour glucose ≥130-140 mg/dL, proceed to Step 2 Step 2: 100-g OGTT; diagnose GDM when at least two values meet or exceed Carpenter-Coustan criteria 4
The one-step method identifies more individuals at risk for long-term maternal diabetes and offspring metabolic complications, with 3.4-fold higher risk of developing prediabetes/type 2 diabetes at 11 years postpartum 4.
Clinical Context
Type 2 diabetes accounts for 90-95% of all diabetes cases and involves relative insulin deficiency with insulin resistance 1. Most individuals have overweight/obesity, though some have normal BMI with increased abdominal fat distribution 1.
Duration of glycemic burden strongly predicts adverse outcomes, making early detection through systematic screening critical rather than waiting for symptomatic presentation 1. Simple, readily available tests can detect preclinical disease, and effective interventions prevent progression from prediabetes to diabetes 1.